RX 821002 hydrochloride

CAS No. 109544-45-8

RX 821002 hydrochloride( —— )

Catalog No. M22727 CAS No. 109544-45-8

RX 821002 hydrochloride is a selective α2-adrenoceptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 36 In Stock
25MG 69 In Stock
50MG 124 In Stock
100MG 198 In Stock
200MG 294 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RX 821002 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    RX 821002 hydrochloride is a selective α2-adrenoceptor antagonist.
  • Description
    RX 821002 hydrochloride is a selective α2-adrenoceptor antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    Adrenergic Receptor
  • Recptor
    α2-adrenoceptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    109544-45-8
  • Formula Weight
    270.72
  • Molecular Formula
    C12H14N2O3·HCl
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 100 mg/mL (369.40 mM)
  • SMILES
    Cl.COC1(COc2ccccc2O1)C1=NCCN1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Clarke R W , Harris J . RX 821002 as a tool for physiological investigation of alpha(2)-adrenoceptors.[J]. C N S Drug Reviews, 2002, 8(2):177-192.
molnova catalog
related products
  • Tizanidine

    Tizanidine is an α2-adrenergic receptor agonist and inhibits neurotransmitter release from CNS noradrenergic neurons.

  • Zinterol hydrochlori...

    Zinterol (MJ 9184) is a potent and selective β2 adrenoceptor agonist with pKb of 8.3, displays >2 logs selectivity over β1 (pKb<5.7).

  • Dicentrine

    Dicentrine is a natural product isolated from the plant Lindera megaphylla with antihypertensive effect. Dicentrine is an α1-adrenoceptor antagonist which has effective against human hyperplastic prostates.